[Form 4] Enovix Corp Insider Trading Activity

Rhea-AI Filing Summary

Enovix Corp (ENVX) reported a routine insider equity transaction by its Chief Financial Officer. On November 21, 2025, the reporting person received 5,729 shares of common stock through a fully vested restricted stock unit (RSU) award that served as a bonus for the quarter ended September 28, 2025, at a stated price of $0 per share. On the same date, 3,028 shares of common stock were withheld at $7.47 per share to cover tax obligations related to this RSU vesting. After these transactions, the reporting person beneficially owned 753,690 shares of Enovix common stock, including 748,752 shares issuable upon settlement of previously granted RSUs.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Benton Ryan A

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,729	$0.00	--
Tax Withholding	Common Stock	3,028	$7.47	$23K

Holdings After Transaction: Common Stock — 756,718 shares (Direct)

Footnotes (1)

1. Reflects shares of the Issuer's common stock issued to the Reporting Person upon the receipt of a fully vested award of restricted stock units ("RSUs") on November 21, 2025. These RSUs represent the Reporting Person's award bonus earned for the quarter ended September 28, 2025. Each RSU represents a contingent right to receive one share of Issuer's common stock. Includes 754,481 shares issuable upon the settlement of RSUs granted to the Reporting Person. Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the receipt of a fully vested award of RSUs on November 21, 2025. Includes 748,752 shares issuable upon the settlement of RSUs granted to the Reporting Person.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Benton Ryan A

(Last) (First) (Middle)

3501 W WARREN AVENUE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		A		5,729(1)	A	$0	756,718(2)	D
Common Stock	11/21/2025		F		3,028(3)	D	$7.47	753,690(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock issued to the Reporting Person upon the receipt of a fully vested award of restricted stock units ("RSUs") on November 21, 2025. These RSUs represent the Reporting Person's award bonus earned for the quarter ended September 28, 2025. Each RSU represents a contingent right to receive one share of Issuer's common stock.

2. Includes 754,481 shares issuable upon the settlement of RSUs granted to the Reporting Person.

3. Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the receipt of a fully vested award of RSUs on November 21, 2025.

4. Includes 748,752 shares issuable upon the settlement of RSUs granted to the Reporting Person.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for Ryan Benton	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.